EspoCRM is an open source customer relationship management application. Prior to version 9.3.4, the admin template management endpoints accept attacker-controlled `name` and `scope` values and pass them into template path construction without normalization or traversal filtering. As a result, an authenticated admin can use `../` sequences to escape the intended template directory and read, create, overwrite, or delete arbitrary files that resolve to `body.tpl` or `subject.tpl` under the web application user's filesystem permissions. Version 9.3.4 fixes the issue.

Project Subscriptions

No data.

Advisories

No advisories yet.

Fixes

Solution

No solution given by the vendor.


Workaround

No workaround given by the vendor.

History

Wed, 22 Apr 2026 20:30:00 +0000

Type Values Removed Values Added
Description EspoCRM is an open source customer relationship management application. Prior to version 9.3.4, the admin template management endpoints accept attacker-controlled `name` and `scope` values and pass them into template path construction without normalization or traversal filtering. As a result, an authenticated admin can use `../` sequences to escape the intended template directory and read, create, overwrite, or delete arbitrary files that resolve to `body.tpl` or `subject.tpl` under the web application user's filesystem permissions. Version 9.3.4 fixes the issue.
Title EspoCRM has Admin TemplateManager path traversal that allows arbitrary file read write and delete
Weaknesses CWE-23
References
Metrics cvssV3_1

{'score': 7.2, 'vector': 'CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H'}


Projects

Sign in to view the affected projects.

cve-icon MITRE

Status: PUBLISHED

Assigner: GitHub_M

Published:

Updated: 2026-04-22T20:05:23.809Z

Reserved: 2026-03-23T17:34:57.560Z

Link: CVE-2026-33733

cve-icon Vulnrichment

No data.

cve-icon NVD

Status : Awaiting Analysis

Published: 2026-04-22T21:17:05.970

Modified: 2026-04-22T21:23:52.620

Link: CVE-2026-33733

cve-icon Redhat

No data.

cve-icon OpenCVE Enrichment

No data.

Weaknesses